ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 55 filers reported holding ADICET BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,911,542 | -37.0% | 2,115,385 | 0.0% | 6.16% | -40.0% |
| Q3 2022 | $30,017,000 | -2.8% | 2,115,385 | 0.0% | 10.26% | +3.8% |
| Q2 2022 | $30,885,000 | -26.7% | 2,115,385 | 0.0% | 9.89% | -17.3% |
| Q1 2022 | $42,160,000 | +14.3% | 2,115,385 | 0.0% | 11.96% | +33.8% |
| Q4 2021 | $36,892,000 | +191.7% | 2,115,385 | +31.0% | 8.94% | +211.5% |
| Q3 2021 | $12,648,000 | -23.7% | 1,615,385 | 0.0% | 2.87% | -44.0% |
| Q2 2021 | $16,574,000 | -21.0% | 1,615,385 | 0.0% | 5.12% | -29.3% |
| Q1 2021 | $20,968,000 | – | 1,615,385 | – | 7.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |